These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 31178419)

  • 21. An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic
    Morgan JM; Lam HN; Delgado J; Luu J; Mohammadi S; Isberg RR; Wang H; Auerbuch V
    Front Cell Infect Microbiol; 2018; 8():404. PubMed ID: 30524970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Amino-Terminal Part of the Needle-Tip Translocator LcrV of
    Ekestubbe S; Bröms JE; Edgren T; Fällman M; Francis MS; Forsberg Å
    Front Cell Infect Microbiol; 2016; 6():175. PubMed ID: 27995096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sequence analysis of the yadA, inv, and ail genes and their expression in the main and nonmain Yersinia pestis subspecies and Yersinia pseudotuberculosis].
    Eroshenko GA; Odinokov GN; Kukleva LM; Krasnov IaM; Kutyrev VV
    Genetika; 2010 Jun; 46(6):734-41. PubMed ID: 20734763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomally-Encoded
    Schesser Bartra S; Lorica C; Qian L; Gong X; Bahnan W; Barreras H; Hernandez R; Li Z; Plano GV; Schesser K
    Front Cell Infect Microbiol; 2019; 9():23. PubMed ID: 30854334
    [No Abstract]   [Full Text] [Related]  

  • 25. Yersinia pestis YopK Inhibits Bacterial Adhesion to Host Cells by Binding to the Extracellular Matrix Adaptor Protein Matrilin-2.
    Tan Y; Liu W; Zhang Q; Cao S; Zhao H; Wang T; Qi Z; Han Y; Song Y; Wang X; Yang R; Du Z
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28533472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiota and Pathogen Proteases Modulate Type III Secretion Activity in Enterohemorrhagic Escherichia coli.
    Cameron EA; Curtis MM; Kumar A; Dunny GM; Sperandio V
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yersinia pseudotuberculosis uses Ail and YadA to circumvent neutrophils by directing Yop translocation during lung infection.
    Paczosa MK; Fisher ML; Maldonado-Arocho FJ; Mecsas J
    Cell Microbiol; 2014 Feb; 16(2):247-68. PubMed ID: 24119087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Yersinia pestis Ail protein mediates binding and Yop delivery to host cells required for plague virulence.
    Felek S; Krukonis ES
    Infect Immun; 2009 Feb; 77(2):825-36. PubMed ID: 19064637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YadA, the multifaceted Yersinia adhesin.
    El Tahir Y; Skurnik M
    Int J Med Microbiol; 2001 Aug; 291(3):209-18. PubMed ID: 11554561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Yersinia pseudotuberculosis adhesin YadA mediates intimate bacterial attachment to and entry into HEp-2 cells.
    Bliska JB; Copass MC; Falkow S
    Infect Immun; 1993 Sep; 61(9):3914-21. PubMed ID: 7689542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic Insights and Its Comparative Analysis with
    Gnanasekaran G; Na EJ; Chung HY; Kim S; Kim YT; Kwak W; Kim H; Ryu S; Choi SH; Lee JH
    J Microbiol Biotechnol; 2017 Feb; 27(2):262-270. PubMed ID: 27974737
    [No Abstract]   [Full Text] [Related]  

  • 32. Yersinia's stratagem: targeting innate and adaptive immune defense.
    Heesemann J; Sing A; Trülzsch K
    Curr Opin Microbiol; 2006 Feb; 9(1):55-61. PubMed ID: 16413818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of
    Pinaud L; Samassa F; Porat Z; Ferrari ML; Belotserkovsky I; Parsot C; Sansonetti PJ; Campbell-Valois FX; Phalipon A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9954-9959. PubMed ID: 28847968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Bordetella Secreted Regulator BspR Is Translocated into the Nucleus of Host Cells via Its N-Terminal Moiety: Evaluation of Bacterial Effector Translocation by the Escherichia coli Type III Secretion System.
    Abe A; Nishimura R; Tanaka N; Kurushima J; Kuwae A
    PLoS One; 2015; 10(8):e0135140. PubMed ID: 26247360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary Hemochromatosis Predisposes Mice to Yersinia pseudotuberculosis Infection Even in the Absence of the Type III Secretion System.
    Miller HK; Schwiesow L; Au-Yeung W; Auerbuch V
    Front Cell Infect Microbiol; 2016; 6():69. PubMed ID: 27446816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors.
    Lam H; Schwochert J; Lao Y; Lau T; Lloyd C; Luu J; Kooner O; Morgan J; Lokey S; Auerbuch V
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staying out or Going in? The Interplay between Type 3 and Type 5 Secretion Systems in Adhesion and Invasion of Enterobacterial Pathogens.
    Whelan R; McVicker G; Leo JC
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The
    Schubert KA; Xu Y; Shao F; Auerbuch V
    Annu Rev Microbiol; 2020 Sep; 74():221-245. PubMed ID: 32660389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yersinia enterocolitica adhesin A induces production of interleukin-8 in epithelial cells.
    Schmid Y; Grassl GA; Bühler OT; Skurnik M; Autenrieth IB; Bohn E
    Infect Immun; 2004 Dec; 72(12):6780-9. PubMed ID: 15557598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivering the pain: an overview of the type III secretion system with special consideration for aquatic pathogens.
    Rahmatelahi H; El-Matbouli M; Menanteau-Ledouble S
    Vet Res; 2021 Dec; 52(1):146. PubMed ID: 34924019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.